FindTrial
Sign In

Multi-center validation study for lung ultrasound for diagnosing lung disease of the newborn in China

Multi-center validation study for lung ultrasound for diagnosing lung disease of the newborn in China

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900023869
Enrollment
Unknown
Registered
2019-06-15
Start date
2019-07-01
Completion date
Unknown
Last updated
2019-06-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung disease of the newborn

Interventions

Gold Standard:There is no gold standard of diseases included. Clinical diagnosis according to medical history, physical examination, X-ray interpretation, disease outcome, treatment response, etc?
Index test:Lung&#32
ultrasound&#32
and&#32
chest&#32
X-ray

Sponsors

The First Hospital of Jilin University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. All infants admitted to NICU will be eligible for the study; 2. Require a CXR to diagnose lung diseases.

Exclusion criteria

Exclusion criteria: 1. Infants with post-menstrual age (PMA) more than 44 weeks; 2. Clinically unstable baby (cant tolerate LUS as per attending physician); 3. Patients with congenital anomalies; 4. infants who recently (within 48h) received surfactant.

Design outcomes

Primary

MeasureTime frame
incidence of adverse event;—

Secondary

MeasureTime frame
sensitivity and specificity of LUS;—

Countries

China

Contacts

Public ContactHui Wu

The First Hospital of Jilin University

wuhui97@126.com+86 15843079689

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026